Lyra Health valuation, funding and investors
Lyra Health works in workforce mental health benefits services, based in Burlingame, United States. Founded in 2015, it has about 2,970 employees.
- Last round
- Series F · $235M · Jan 2022
- Valuation at last round
- $5.90B
- Headcount
- 2,973 · up
- Grade
- D
- Founded
- 2015
Lyra Health valuation today
VCMC values Lyra Health at $6.6B today, with a range of $974M to $9.9B and a grade of D. The valuation starts from its last funding round, a Series F round in Jan 2022.
Valuation by date (149 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2015 | $5.25M | $1.91M – $14.4M | $5.51M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2015 | $5.28M | $1.92M – $14.5M | $5.53M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2015 | $5.29M | $1.93M – $14.5M | $5.55M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2015 | $5.32M | $1.93M – $14.6M | $5.57M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2015 | $5.34M | $1.94M – $14.7M | $5.59M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2015 | $5.36M | $1.95M – $14.7M | $5.61M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2015 | $5.38M | $1.96M – $14.8M | $5.64M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2015 | $5.40M | $1.97M – $14.8M | $5.78M (+7%) | before first round | – | unknown | D | 0% |
| 1 Sep 2015 | $5.42M | $1.97M – $14.9M | $5.94M (+10%) | before first round | – | unknown | D | 0% |
| 1 Oct 2015 | $5.44M | $1.98M – $14.9M | $6.09M (+12%) | before first round | – | unknown | D | 0% |
| 15 Oct 2015 | $195M | $128M – $533M | $350M (+80%) | after a round | – | unknown | C | 0% |
| 1 Nov 2015 | $200M | $128M – $533M | $350M (+75%) | after a round | – | unknown | C | 0% |
| 1 Dec 2015 | $210M | $128M – $533M | $350M (+67%) | after a round | – | unknown | C | 0% |
| 1 Jan 2016 | $221M | $128M – $533M | $350M (+59%) | after a round | – | unknown | C | 0% |
| 1 Feb 2016 | $232M | $128M – $533M | $350M (+51%) | after a round | – | unknown | C | 0% |
| 1 Mar 2016 | $243M | $128M – $533M | $350M (+44%) | after a round | – | unknown | C | 0% |
| 1 Apr 2016 | $256M | $128M – $533M | $350M (+37%) | after a round | – | unknown | C | 0% |
| 1 May 2016 | $268M | $128M – $533M | $350M (+30%) | after a round | – | unknown | C | 0% |
| 1 Jun 2016 | $282M | $128M – $533M | $350M (+24%) | after a round | – | unknown | C | 0% |
| 1 Jul 2016 | $296M | $128M – $533M | $350M (+18%) | after a round | – | unknown | C | 0% |
| 1 Aug 2016 | $311M | $128M – $533M | $350M (+13%) | after a round | – | unknown | C | 0% |
| 1 Sep 2016 | $327M | $128M – $533M | $350M (+7%) | after a round | – | unknown | C | 0% |
| 1 Oct 2016 | $343M | $128M – $533M | $350M (+2%) | after a round | – | unknown | C | 0% |
| 1 Nov 2016 | $350M | $124M – $533M | $350M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2016 | $350M | $118M – $533M | $350M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2017 | $350M | $112M – $533M | $350M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2017 | $350M | $107M – $533M | $350M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2017 | $350M | $102M – $533M | $350M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2017 | $350M | $96.7M – $533M | $350M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2017 | $350M | $92.0M – $533M | $350M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2017 | $350M | $87.5M – $533M | $350M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2017 | $350M | $83.2M – $533M | $350M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2017 | $350M | $79.1M – $533M | $350M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2017 | $350M | $75.2M – $533M | $350M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2017 | $350M | $71.6M – $533M | $350M (0%) | after a round | – | unknown | D | 0% |
| 1 Nov 2017 | $350M | $68.0M – $533M | $350M (0%) | after a round | – | unknown | D | 0% |
| 1 Dec 2017 | $350M | $64.7M – $533M | $350M (0%) | after a round | – | unknown | D | 0% |
| 1 Jan 2018 | $350M | $61.5M – $533M | $350M (0%) | after a round | – | unknown | D | 0% |
| 1 Feb 2018 | $350M | $58.5M – $533M | $350M (0%) | after a round | – | unknown | D | 0% |
| 1 Mar 2018 | $350M | $55.8M – $533M | $350M (0%) | after a round | – | unknown | D | 0% |
| 1 Apr 2018 | $350M | $53.1M – $533M | $350M (0%) | after a round | – | unknown | D | 0% |
| 1 May 2018 | $350M | $50.5M – $533M | $350M (0%) | after a round | – | unknown | D | 0% |
| 8 May 2018 | $324M | $228M – $688M | $485M (+50%) | after a round | – | unknown | B | 0% |
| 1 Jun 2018 | $333M | $228M – $688M | $485M (+46%) | after a round | – | unknown | B | 0% |
| 1 Jul 2018 | $344M | $228M – $688M | $485M (+41%) | after a round | – | unknown | B | 0% |
| 1 Aug 2018 | $356M | $228M – $688M | $485M (+36%) | after a round | – | unknown | B | 0% |
| 1 Sep 2018 | $368M | $228M – $688M | $485M (+32%) | after a round | – | unknown | B | 0% |
| 1 Oct 2018 | $381M | $228M – $688M | $485M (+27%) | after a round | – | unknown | B | 0% |
| 1 Nov 2018 | $394M | $228M – $688M | $485M (+23%) | after a round | – | unknown | B | 0% |
| 1 Dec 2018 | $407M | $228M – $688M | $485M (+19%) | after a round | – | unknown | B | 0% |
| 1 Jan 2019 | $422M | $228M – $688M | $485M (+15%) | after a round | – | unknown | B | 0% |
| 1 Feb 2019 | $436M | $228M – $688M | $485M (+11%) | after a round | – | unknown | B | 0% |
| 1 Mar 2019 | $450M | $228M – $688M | $485M (+8%) | after a round | – | unknown | B | 0% |
| 1 Apr 2019 | $466M | $228M – $688M | $485M (+4%) | after a round | – | unknown | B | 0% |
| 1 May 2019 | $482M | $228M – $688M | $485M (+1%) | after a round | – | unknown | B | 0% |
| 1 Jun 2019 | $485M | $220M – $688M | $485M (0%) | after a round | – | unknown | B | 0% |
| 1 Jul 2019 | $485M | $211M – $688M | $485M (0%) | after a round | – | unknown | B | 0% |
| 1 Aug 2019 | $485M | $202M – $688M | $485M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2019 | $485M | $193M – $688M | $485M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2019 | $485M | $185M – $688M | $485M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2019 | $485M | $177M – $688M | $485M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2019 | $485M | $169M – $688M | $485M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2020 | $485M | $162M – $688M | $485M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2020 | $485M | $155M – $688M | $485M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2020 | $485M | $149M – $688M | $485M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2020 | $485M | $142M – $688M | $485M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2020 | $485M | $136M – $688M | $485M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2020 | $485M | $120M – $688M | $485M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2020 | $485M | $114M – $688M | $485M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2020 | $485M | $109M – $688M | $485M (0%) | after a round | – | unknown | C | 0% |
| 26 Aug 2020 | $1.1B | $956M – $1.6B | $1.4B (+30%) | after a round | – | unknown | A | 0% |
| 1 Sep 2020 | $1.1B | $956M – $1.6B | $1.4B (+29%) | after a round | – | unknown | A | 0% |
| 1 Oct 2020 | $1.1B | $956M – $1.6B | $1.4B (+27%) | after a round | – | unknown | A | 0% |
| 1 Nov 2020 | $1.2B | $956M – $1.6B | $1.4B (+24%) | after a round | – | unknown | A | 0% |
| 1 Dec 2020 | $1.2B | $956M – $1.6B | $1.4B (+21%) | after a round | – | unknown | A | 0% |
| 1 Jan 2021 | $1.2B | $956M – $1.6B | $1.4B (+18%) | after a round | 390 | unknown | A | 0% |
| 29 Jan 2021 | $2.3B | $2.0B – $3.4B | $3.0B (+30%) | after a round | 390 | unknown | A | 0% |
| 1 Feb 2021 | $2.3B | $2.0B – $3.4B | $3.0B (+30%) | after a round | 390 | unknown | A | 0% |
| 1 Mar 2021 | $2.4B | $2.0B – $3.4B | $3.0B (+27%) | after a round | 390 | unknown | A | 0% |
| 1 Apr 2021 | $2.4B | $2.0B – $3.4B | $3.0B (+24%) | after a round | 390 | flat | A | 0% |
| 1 May 2021 | $2.5B | $2.0B – $3.4B | $3.0B (+22%) | after a round | 390 | flat | A | 0% |
| 1 Jun 2021 | $2.5B | $2.0B – $3.4B | $3.0B (+19%) | after a round | 390 | flat | A | 0% |
| 16 Jun 2021 | $4.6B | $4.0B – $5.8B | $5.1B (+10%) | after a round | 390 | flat | A | 0% |
| 1 Jul 2021 | $4.6B | $4.0B – $5.8B | $5.1B (+10%) | after a round | 390 | flat | A | 0% |
| 1 Aug 2021 | $4.7B | $4.0B – $5.8B | $5.1B (+9%) | after a round | 390 | flat | A | 0% |
| 1 Sep 2021 | $4.7B | $4.0B – $5.8B | $5.1B (+8%) | after a round | 390 | flat | A | 0% |
| 1 Oct 2021 | $4.7B | $4.0B – $5.8B | $5.1B (+7%) | after a round | 390 | flat | A | 0% |
| 1 Nov 2021 | $4.8B | $4.0B – $5.8B | $5.1B (+6%) | after a round | 390 | flat | A | 0% |
| 1 Dec 2021 | $4.8B | $4.0B – $5.8B | $5.1B (+5%) | after a round | 390 | flat | A | 0% |
| 1 Jan 2022 | $4.8B | $4.0B – $5.8B | $5.1B (+4%) | after a round | 390 | flat | A | 0% |
| 20 Jan 2022 | $5.9B | $5.1B – $8.8B | $7.7B (+30%) | after a round | 390 | flat | A | 0% |
| 1 Feb 2022 | $6.0B | $5.1B – $8.8B | $7.7B (+29%) | after a round | 1,200 | growing | A | 0% |
| 1 Mar 2022 | $6.1B | $5.1B – $8.8B | $7.7B (+26%) | after a round | 1,200 | growing | A | 0% |
| 1 Apr 2022 | $6.2B | $5.1B – $8.8B | $7.7B (+23%) | after a round | 1,200 | growing | A | 0% |
| 1 May 2022 | $6.3B | $5.1B – $8.8B | $7.7B (+21%) | after a round | 1,200 | growing | A | 0% |
| 1 Jun 2022 | $6.5B | $5.1B – $8.8B | $7.7B (+18%) | after a round | 1,200 | growing | A | 0% |
| 1 Jul 2022 | $6.6B | $5.1B – $8.8B | $7.7B (+16%) | after a round | 1,200 | growing | A | 0% |
| 1 Aug 2022 | $6.8B | $5.1B – $8.8B | $7.7B (+13%) | after a round | 1,200 | growing | A | 0% |
| 1 Sep 2022 | $6.9B | $5.1B – $8.8B | $7.7B (+11%) | after a round | 1,200 | growing | A | 0% |
| 1 Oct 2022 | $7.1B | $5.1B – $8.8B | $7.7B (+8%) | after a round | 1,200 | growing | A | 0% |
| 1 Nov 2022 | $7.2B | $5.1B – $8.8B | $7.7B (+6%) | after a round | 1,200 | unknown | A | 0% |
| 1 Dec 2022 | $7.4B | $5.1B – $8.8B | $7.7B (+4%) | after a round | 1,200 | unknown | A | 0% |
| 1 Jan 2023 | $7.6B | $5.1B – $8.8B | $7.7B (+1%) | after a round | 1,200 | unknown | A | 0% |
| 1 Feb 2023 | $7.7B | $5.0B – $8.8B | $7.7B (0%) | after a round | 1,200 | unknown | A | 0% |
| 1 Mar 2023 | $7.7B | $4.8B – $8.8B | $7.7B (0%) | after a round | 1,200 | unknown | B | 0% |
| 1 Apr 2023 | $8.5B | $5.3B – $9.8B | $8.5B (0%) | after a round | 1,900 | growing | B | 0% |
| 1 May 2023 | $8.5B | $5.4B – $9.8B | $8.5B (0%) | after a round | 1,900 | growing | A | 0% |
| 1 Jun 2023 | $8.5B | $5.5B – $9.8B | $8.5B (0%) | after a round | 1,900 | growing | A | 0% |
| 1 Jul 2023 | $8.5B | $5.5B – $9.8B | $8.5B (0%) | after a round | 1,900 | growing | A | 0% |
| 1 Aug 2023 | $8.5B | $5.6B – $9.8B | $8.5B (0%) | after a round | 1,900 | growing | A | 0% |
| 1 Sep 2023 | $8.5B | $3.9B – $9.8B | $8.5B (0%) | after a round | 1,900 | unknown | B | 0% |
| 1 Oct 2023 | $8.8B | $5.1B – $10.1B | $8.8B (0%) | after a round | 2,200 | up | B | 0% |
| 1 Nov 2023 | $8.8B | $5.1B – $10.1B | $8.8B (0%) | after a round | 2,200 | up | B | 0% |
| 1 Dec 2023 | $8.8B | $5.1B – $10.1B | $8.8B (0%) | after a round | 2,200 | up | B | 0% |
| 1 Jan 2024 | $8.8B | $5.1B – $10.1B | $8.8B (0%) | after a round | 2,200 | up | B | 0% |
| 1 Feb 2024 | $8.8B | $4.6B – $10.1B | $8.7B (0%) | after a round | 2,200 | up | B | 0% |
| 1 Mar 2024 | $8.9B | $4.6B – $10.2B | $8.8B (0%) | after a round | 2,300 | up | B | 0% |
| 1 Apr 2024 | $8.9B | $4.5B – $10.2B | $8.8B (-1%) | after a round | 2,300 | up | B | 0% |
| 1 May 2024 | $8.9B | $4.4B – $10.2B | $8.7B (-1%) | after a round | 2,300 | up | B | 0% |
| 1 Jun 2024 | $8.9B | $4.4B – $10.2B | $8.7B (-2%) | after a round | 2,300 | up | B | 0% |
| 1 Jul 2024 | $8.9B | $4.3B – $10.2B | $8.7B (-2%) | after a round | 2,300 | up | B | 0% |
| 1 Aug 2024 | $8.9B | $4.2B – $10.3B | $8.8B (-1%) | after a round | 2,400 | up | B | 0% |
| 1 Sep 2024 | $8.9B | $4.2B – $10.3B | $8.8B (-2%) | after a round | 2,400 | up | B | 0% |
| 1 Oct 2024 | $8.9B | $4.1B – $10.3B | $8.8B (-2%) | after a round | 2,400 | up | B | 0% |
| 1 Nov 2024 | $8.9B | $2.0B – $10.3B | $8.5B (-5%) | after a round | 2,400 | flat | C | 0% |
| 1 Dec 2024 | $8.9B | $1.9B – $10.3B | $8.4B (-6%) | after a round | 2,400 | flat | C | 0% |
| 1 Jan 2025 | $8.9B | $1.9B – $10.3B | $8.4B (-6%) | after a round | 2,400 | flat | C | 0% |
| 1 Feb 2025 | $8.9B | $1.8B – $10.3B | $8.3B (-6%) | after a round | 2,400 | flat | C | 0% |
| 1 Mar 2025 | $8.9B | $1.7B – $10.2B | $8.3B (-6%) | after a round | 2,400 | flat | C | 0% |
| 1 Apr 2025 | $8.8B | $1.6B – $10.2B | $8.3B (-6%) | after a round | 2,415 | flat | C | 0% |
| 1 May 2025 | $8.8B | $1.5B – $10.1B | $8.2B (-7%) | after a round | 2,415 | flat | C | 0% |
| 1 Jun 2025 | $8.7B | $1.4B – $10.0B | $8.1B (-7%) | after a round | 2,415 | flat | C | 0% |
| 1 Jul 2025 | $8.8B | $2.6B – $10.1B | $8.2B (-6%) | after a round | 2,517 | up | C | 0% |
| 1 Aug 2025 | $8.8B | $2.5B – $10.1B | $8.3B (-6%) | after a round | 2,562 | up | C | 0% |
| 1 Sep 2025 | $8.7B | $2.4B – $10.0B | $8.1B (-7%) | after a round | 2,562 | up | C | 0% |
| 1 Oct 2025 | $8.6B | $1.2B – $9.9B | $7.9B (-8%) | after a round | 2,562 | flat | D | 0% |
| 1 Nov 2025 | $8.6B | $1.1B – $9.9B | $8.0B (-7%) | after a round | 2,610 | flat | D | 0% |
| 1 Dec 2025 | $8.6B | $1.1B – $9.8B | $8.0B (-7%) | after a round | 2,610 | flat | D | 0% |
| 1 Jan 2026 | $8.5B | $1.0B – $9.8B | $7.9B (-7%) | after a round | 2,610 | flat | D | 0% |
| 1 Feb 2026 | $8.5B | $985M – $9.7B | $7.9B (-7%) | after a round | 2,610 | flat | D | 0% |
| 1 Mar 2026 | $8.4B | $940M – $9.7B | $7.9B (-7%) | after a round | 2,610 | flat | D | 0% |
| 1 Apr 2026 | $8.7B | $1.6B – $10.0B | $8.3B (-5%) | after a round | 2,780 | up | C | 0% |
| 1 May 2026 | $8.7B | $1.6B – $10.0B | $8.3B (-5%) | after a round | 2,780 | up | C | 0% |
| 1 Jun 2026 | $8.6B | $1.5B – $9.8B | $8.1B (-5%) | after a round | 2,780 | up | C | 0% |
| 1 Jul 2026 | $8.5B | $1.4B – $9.8B | $8.1B (-5%) | after a round | 2,780 | up | C | 0% |
| 1 Aug 2026 | $8.5B | $1.4B – $9.8B | $8.0B (-5%) | after a round | 2,780 | up | C | 0% |
| 1 Sep 2026 | $8.4B | $1.3B – $9.7B | $8.0B (-5%) | after a round | 2,780 | up | C | 0% |
| 1 Oct 2026 | $8.9B | $1.3B – $10.2B | $8.6B (-3%) | after a round | 2,973 | up | D | 0% |
| 24 Oct 2026 | $6.6B | $974M – $9.9B | $6.3B (-4%) | after a round | 2,973 | up | D | 0% |
Key facts about Lyra Health
- Founded
- 2015
- Headquarters
- Burlingame, United States
- Employees
- about 2,970 +14% in a year
- Total raised
- $812M
- Funding rounds
- 6
- Last round
- Series F Jan 2022
Lyra Health was founded in 2015 by Bob Kocher, David Ebersman and Sean McBride.
Lyra Health funding history
Lyra Health has 6 funding rounds on record, from Oct 2015 to Jan 2022, $812M in total. The latest disclosed valuation is $5.90B post-money (Series F, Jan 2022).
Series F 19 Jan 2022
Led by Dragoneer Investment Group; with Coatue, Salesforce Ventures.
Sources: healthtechnerds.com, therapycompanion.ai, lyrahealth.com and 1 more
$235M
$5.90B post-money
Growth Equity 15 Jun 2021
Led by Coatue; with Sands Capital.
Sources: finsmes.com, healthcareweekly.com, lyrahealth.com and 2 more
$200M
$4.60B post-money
Series E 28 Jan 2021
Led by Addition; with Durable Capital Partners, Fidelity Management & Research Company, Baillie Gifford.
Sources: lyrahealth.com, prnewswire.com, mobihealthnews.com and 1 more
$187M
$2.30B post-money
Series D 25 Aug 2020
Led by Addition; with Adams Street Partners, Casdin Capital, Glynn Capital, Greylock Partners, Institutional Venture Partners, Meritech Capital, Providence Ventures, Tenaya Capital, Starbucks chairman emeritus and former CEO Howard Schultz, Maveron.
Sources: lyrahealth.com, mobihealthnews.com, bhbusiness.com
$110M
$1.10B post-money
Series B 7 May 2018
With Tenaya Capital, Glynn Capital, Crown Ventures, Casdin Capital, Greylock Partners, Venrock, Providence Ventures.
Sources: lyrahealth.com, lyrahealth.com, mobihealthnews.com and 4 more
$45M
Series A 14 Oct 2015
Led by Greylock Partners, Venrock; with Castlight Health, Providence Health & Services, Breyer Capital, Origin Capital.
Sources: finsmes.com, biospace.com, healthcaredive.com and 1 more
$35M
Lyra Health investors
24 investors have backed Lyra Health; Greylock Partners, Addition and Coatue and 2 more led at least one round.
- Greylock Partners lead, 3 rounds
- Addition lead, 2 rounds
- Coatue lead, 2 rounds
- Venrock lead, 2 rounds
- Dragoneer Investment Group lead
- Adams Street Partners
- Baillie Gifford
- Breyer Capital
- Castlight Health
- Crown Ventures
- Durable Capital Partners
- Fidelity Management & Research Company
- Institutional Venture Partners
- Meritech Capital
- Providence Health & Services
- Salesforce Ventures
- Sands Capital
- Starbucks chairman emeritus and former CEO Howard Schultz
What Lyra Health does
Lyra Health works in psychologists & counseling services, with 12 recorded offerings and customers in healthcare and corporate/business services.
Lyra Health, Inc. is an American company that provides mental health care solutions, including mental health coaching, therapy, medication management, and workforce transformation programs. The company operates a digital platform that connects individuals and organizations with licensed clinicians and mental health professionals, and offers self-care tools and AI-powered provider matching. Lyra Health serves employers, health plans, and individuals, and is involved in research and development related to mental health care.
Description from Veridion's company data.
Products and services
- Workforce Mental Health Benefits Services
- Mental Health Coaching Services
- Live Therapy Session Services
- Digital Medication Management Services
- AI-Powered Provider Matching Services
- Real-Time Mental Health Support Services
- Self-Care Tool Access Services
- Clinical Research and Evidence Development
- Mental Health Care Technology Development
- Mental Health Care Access Improvement Services
- Employee Productivity Enhancement Services
- Mental Health Care Cost Reduction Services
Markets
- Healthcare
- Corporate/Business Services
Technology
- AI-Powered Provider Matching
- Real-Time Support Systems
- Proprietary Self-Care Tools
Business model
- Business-to-Business
- Business-to-Consumer
- Service Provider
- Healthcare
Industry codes (NAICS)
- 621330 Offices of Mental Health Practitioners (except Physicians) 70% match
- 541512 Computer Systems Design Services 30% match
Questions about Lyra Health
What is Lyra Health worth?
Valuation $6.6B (range $974M to $9.9B), as of 24 Oct 2026. The last disclosed valuation was $5.90B (Series F, Jan 2022).
Has Lyra Health raised money?
Lyra Health has 6 funding rounds on record, from Oct 2015 to Jan 2022, $812M in total. The latest disclosed valuation is $5.90B post-money (Series F, Jan 2022).
Who has invested in Lyra Health?
Greylock Partners, Addition, Coatue, Venrock, Dragoneer Investment Group and Casdin Capital, and 18 more. Lead investors include Greylock Partners, Addition, Coatue and Venrock.
How many people work at Lyra Health?
About 2,970, up 14% over the last year. Headcount grew from 390 in Jan 2021 to 2,973 in Sep 2026.
What does Lyra Health do?
Lyra Health works in psychologists & counseling services, with 12 recorded offerings and customers in healthcare and corporate/business services. Its main offerings are workforce mental health benefits services, mental health coaching services and live therapy session services.
When was Lyra Health founded, and where is it based?
Lyra Health was founded in 2015 and is based in Burlingame, United States. It has about 2,970 employees, up 14% over the last year.